Skip to main content
Book
Management of Osteoporosis in Postmenopausal Breast Cancer Survivors
Essentials of Menopause Management
  • Xuezhi Jiang, Department of Obstetrics and Gynecology, Reading Hospital, Reading, PA and Sidney Kimmel Medical College of Thomas Jefferson University, Department of ObGyn, Philadelphia, PA
  • Peter F Schnatz, Departments of Obstetrics and Gynecology and Internal Medicine, Reading Hospital, Reading, PA and Sidney Kimmel Medical College of Thomas Jefferson University, Department of ObGyn, Philadelphia, PA
  • Risa Kagan, East Bay Physicians Medical Group, Berkeley, CA and University of California, Department of Obstetrics, Gynecology, and Reproductive Sciences, San Francisco, CA
Document Type
Book
Publication Date
2-2-2017
Abstract

A 55-year-old Caucasian postmenopausal woman with BMI of 22.5 kg/m2 presents to the clinic for follow-up to discuss the results of her recent dual-energy X-ray absorptiometry (DXA) bone mineral density (BMD) scan. She has a personal history of premenopausal early-stage hormone receptor-positive breast cancer at age 47 and a family history of parental hip fracture. Following her initial breast cancer treatment, she received tamoxifen for 5 years (Age 47–52) followed by anastrozole (an aromatase inhibitor) until the current time. The DXA scan reports T-scores of −1.8 at the total hip and −1.6 at the lumbar spine. What would be your preferred management?

Comments

Book Chapter - pages 285-301

  • Print ISBN:978-3-319-42449-1
  • Online ISBN:978-3-319-42451-4
Citation Information
Xuezhi Jiang, Peter F Schnatz and Risa Kagan. Management of Osteoporosis in Postmenopausal Breast Cancer Survivors. Essentials of Menopause Management (2017) p. 285 - 301
Available at: http://works.bepress.com/xuezhi-jiang/100/